IgG (mg/dL) |
509 (600–1700) |
IgM (mg/dL) |
242 (35–290) |
IgA (mg/dL) |
< 8 (40–400) |
Diphtheria IgG titer (IU/mL) |
0.11 (≥ 0.15) |
Tetanus IgG titer (IU/mL) |
0.48 (≥ 0.15) |
Pneumococcal titers for PCV13 serotypes |
2/12 protective serotypes (> 70% protective) |
Absolute lymphocyte count (cells/mcL) |
1000 (1500–5000) |
Absolute CD3 count (cells/mcL) |
813 (915–3400) |
Absolute CD4 count (cells/mcL) |
443 (510–2320) |
Absolute CD8 count (cells/mcL) |
371 (180–1520) |
Absolute CD19 count (cells/mcL) |
132 (105–920) |
Absolute CD16/56 count (cells/mcL) |
251 (15–1080) |
Absolute CD4+CD45+RA+ count (cells/mcL) |
13 (135–893) |
Absolute CD8+CD45+RA+ count (cells/mcL) |
173 (83–653) |
CD3% proliferation to PHA |
16% (> 58.5%) |
CD3% proliferation to PWM |
5.0% (> 3.5%) |
CD3% proliferation to CA |
0.0% (> 3.0%) |
CD3% proliferation to TT |
2.3% (> 3.3%) |